Evidence map›Paper›PMID 33554526›Full record

ReviewDiagnosis (Berlin, Germany)2021

Bringing the clinical laboratory into the strategy to advance diagnostic excellence.

Ira M Lubin, J Rex Astles, Shahram Shahangian, Bereneice Madison, Ritchard Parry, Robert L Schmidt, Matthew L Rubinstein

Abstract readReview
In one paragraph

Review in Diagnosis (Berlin, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Application and Impact of Quality Assurance Dashboards in Cytology Laboratories-The CytoLog Application.Cytopathology : official journal of the British Society for Clinical Cytology · 2026
    Article
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ira M LubinDivision of Laboratory Systems, Centers for Disease Control and Prevention, Atlanta, GA, USA.
J Rex AstlesDivision of Laboratory Systems, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Shahram ShahangianDivision of Laboratory Systems, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Bereneice MadisonDivision of Laboratory Systems, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ritchard ParryDivision of Laboratory Systems, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Robert L SchmidtDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA.
Matthew L RubinsteinDepartment of Clinical Laboratory and Medical Imaging Sciences, Rutgers, The State University of New Jersey, Newark, NJ, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectivesClinical laboratory testing provides essential data for making medical diagnoses. Generating accurate and timely test results clearly communicated to the treating clinician, and ultimately the patient, is a critical component that supports diagnostic excellence. On the other hand, failure to achieve this can lead to diagnostic errors that manifest in missed, delayed and wrong diagnoses. CONTENT: Innovations that support diagnostic excellence address: 1) test utilization, 2) leveraging clinical and laboratory data, 3) promoting the use of credible information resources, 4) enhancing communication among laboratory professionals, health care providers and the patient, and 5) advancing the use of diagnostic management teams. Integrating evidence-based laboratory and patient-care quality management approaches may provide a strategy to support diagnostic excellence. Professional societies, government agencies, and healthcare systems are actively engaged in efforts to advance diagnostic excellence. Leveraging clinical laboratory capabilities within a healthcare system can measurably improve the diagnostic process and reduce diagnostic errors. SUMMARY: An expanded quality management approach that builds on existing processes and measures can promote diagnostic excellence and provide a pathway to transition innovative concepts to practice. OUTLOOK: There are increasing opportunities for clinical laboratory professionals and organizations to be part of a strategy to improve diagnoses.

Indexed as

Clinical Laboratory ServicesLaboratoriesCommunicationDelivery of Health CareDiagnostic ErrorsHumansdiagnostic errordiagnostic excellencelaboratory practicequality

Identifiers

PMID33554526
PMCPMC8255320

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.